Virtuix Holdings Inc. has secured the 2026 Auggie Award for Best Interaction Product for its Omni One platform, recognizing its application in humanoid robot teleoperation. The award, presented at the Augmented World Expo (AWE), highlights the platform's role in a project developed by the University of Central Florida’s Institute for Simulation & Training (IST). This marks the second consecutive year Virtuix has won this category, reinforcing its position in the XR, AI, and robotics sectors.

Humanoid Robotics and AI Integration

The Omni One platform was honored as part of the "Being there without being there" project, an immersive system that allows operators to control a humanoid robot in real time by walking on the omni-directional treadmill. This teleoperation capability addresses the growing need for intuitive control methods and physical AI training in the robotics industry. By capturing natural, unrestricted full-body movement, the platform enables the collection of data necessary to train autonomous robot behaviors.

Strategic Partnerships and Expansion

Building on this momentum, Virtuix recently partnered with 1HMX to develop the Nexus NX1, a full-body humanoid robot control system. This system integrates the Omni One Enterprise treadmill with HaptX Gloves G1, allowing operators to control robots and generate high-quality movement data for embodied AI systems. The company continues to expand its technology into aerospace, defense, healthcare, and enterprise markets.

Recognition and Industry Impact

Jan Goetgeluk, Founder and CEO of Virtuix, stated that the award validates Omni One as a foundational movement technology for intelligent machines. Dr. Carolina Cruz-Neira, Executive Director of IST at the University of Central Florida, emphasized that immersive environments combined with natural locomotion create a true sense of presence. The Auggie Awards, determined by public voting and expert judging, are considered the highest honor in the XR industry.

Key Details

Virtuix Holdings Inc. has entered a strategic partnership with Sirica Therapeutics to deploy its Omni One platform for immersive autism therapy applications. The collaboration aims to enhance engagement and treatment outcomes for children with autism and related disorders using movement-centered virtual reality and AI-assisted therapeutic experiences. This partnership supports Sirica's plan to establish approximately 100 Sirica Centers across the United States, creating a nationwide network of specialized autism treatment facilities.

As part of the initial deployment, Virtuix has sold and shipped the first two Omni One systems to Sirica's treatment center in the San Francisco Bay Area. The partnership builds on Virtuix's ongoing research collaborations with Rutgers University and Florida Gulf Coast University, focusing on AI-assisted neurodivergent therapy and neurological rehabilitation. These initiatives align with Virtuix's strategy to expand its immersive simulation platform into clinical environments.

The collaboration leverages Rutgers University research to advance the application of movement-based technologies in healthcare. Virtuix aims to extend its reach into clinical settings where its technologies may improve patient engagement and therapy efficacy. Sirica's nationwide expansion plan underscores the scalability of the Omni One platform in addressing autism treatment needs.

Partnership Details

Strategic Context

Virtuix's partnership with Sirica follows its research collaborations with Rutgers University and Florida Gulf Coast University. These efforts highlight the company's focus on integrating its full-body simulation systems into healthcare applications. The Omni One platform is designed to support movement-based therapies, which may offer new avenues for treating neurodivergent conditions and neurological disorders.